Evaluation of risk factors for uric acid elevation in COVID-19 patients treated with favipiravir

The objective of this retrospective study was to identify the clinical risk factor associated with uric acid elevation in coronavirus disease (COVID-19) patients treated with favipiravir. Uric acid elevation was defined as an unexplained increase of ≥1.5 times in the patient's uric acid level f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanai, Yuki, Yoshizawa, Sadako, Matsuo, Kazuhiro, Uekusa, Shusuke, Miyazaki, Taito, Nishimura, Koji, Mabuchi, Takumi, Ohashi, Hayato, Ishii, Yoshikazu, Tateda, Kazuhiro, Yoshio, Takashi, Nishizawa, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782729/
https://www.ncbi.nlm.nih.gov/pubmed/35193798
http://dx.doi.org/10.1016/j.diagmicrobio.2022.115640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782729/
https://www.ncbi.nlm.nih.gov/pubmed/35193798
http://dx.doi.org/10.1016/j.diagmicrobio.2022.115640

Ejemplares similares